Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care

Research output: Contribution to journalReviewResearchpeer-review

DOI

  1. Causes of Death in People with Dementia from 2002 to 2015: A Nationwide Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Comparing a Single Clinician Versus a Multidisciplinary Consensus Conference Approach for Dementia Diagnostics

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Is the Frontal Lobe the Primary Target of SARS-CoV-2?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Guidelines should be guidelines: Time to leave the terms "consensus" and "position" for other purposes

    Research output: Contribution to journalEditorialResearchpeer-review

  2. Kronisk Traumatisk Encefalopati

    Research output: Contribution to journalReviewResearchpeer-review

  3. Atrial fibrillation burden and cognitive decline in elderly patients undergoing continuous monitoring

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Sofia Toniolo
  • Marta Scarioni
  • Francesco Di Lorenzo
  • Jakub Hort
  • Jean Georges
  • Svetlana Tomic
  • Flavio Nobili
  • Kristian Steen Frederiksen
  • Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel
View graph of relations

Cognitive impairment following SARS-CoV-2 infection is being increasingly recognized as an acute and possibly also long-term sequela of the disease. Direct viral entry as well as systemic mechanisms such as cytokine storm are thought to contribute to neuroinflammation in these patients. Biomarkers of COVID-19-induced cognitive impairment are currently lacking, but there is some limited evidence that SARS-CoV-2 could preferentially target the frontal lobes, as suggested by behavioral and dysexecutive symptoms, fronto-temporal hypoperfusion on MRI, EEG slowing in frontal regions, and frontal hypometabolism on 18F-FDG-PET. Possible confounders include cognitive impairment due to hypoxia and mechanical ventilation and post-traumatic stress disorder. Conversely, patients already suffering from dementia, as well as their caregivers, have been greatly impacted by the disruption of their care caused by COVID-19. Patients with dementia have experienced worsening of cognitive, behavioral, and psychological symptoms, and the rate of COVID-19-related deaths is disproportionately high among cognitively impaired people. Multiple factors, such as difficulties in remembering and executing safeguarding procedures, age, comorbidities, residing in care homes, and poorer access to hospital standard of care play a role in the increased morbidity and mortality. Non-pharmacological interventions and new technologies have shown a potential for the management of patients with dementia, and for the support of their caregivers.

Original languageEnglish
JournalJournal of Alzheimer's Disease
Volume82
Issue number3
Pages (from-to)883-898
Number of pages16
ISSN1387-2877
DOIs
Publication statusPublished - 2021

    Research areas

  • Alzheimer Disease/physiopathology, Biomarkers/analysis, Brain/diagnostic imaging, COVID-19/complications, Cognitive Dysfunction/immunology, Comorbidity, Humans, Neuroimaging/methods, Neuroimmunomodulation/immunology, Patient Care, SARS-CoV-2

ID: 68398105